Pretreatment prostate specific antigen doubling time as prognostic factor in prostate cancer patients

Despite the prostate-specific antigen (PSA) serum level commonly uses as tumor marker in diagnosis of prostate cancer, it seems that PSA doubling time (PSADT) could be more useful indicator of tumor behavior and of prognosis for patients. The results of hormone and radiation therapy were evaluated f...

Descripción completa

Detalles Bibliográficos
Autores principales: Zharinov, Gennady M., Bogomolov, Oleg A., Neklasova, Natalia N., Anisimov, Vladimir N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5361642/
https://www.ncbi.nlm.nih.gov/pubmed/28484728
http://dx.doi.org/10.18632/oncoscience.337

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5361642/
https://www.ncbi.nlm.nih.gov/pubmed/28484728
http://dx.doi.org/10.18632/oncoscience.337

Ejemplares similares